Cancer Research

 
Stock Quotes for Cancer Research top ^
  • Industry: Health Information Services
  • Sector: Technology
  • Stock Type: Distressed
Sign-up for cthz investment picks

 
News Articles for Cancer Research top ^
Cancer Research Technology Ltd.
Sign-up for Cancer Research Technology and Teva Pharmaceuticals Form R&D Alliance for Cancer DNA Damage Response Drugs investment picks
Company Donates Record Breaking $4 Million to Benefit The Breast Cancer Research Foundation® NEW YORK , Oct.
Sign-up for ANN INC. Rallies in Support of the Fight Against Breast Cancer with Launch of Annual Giving Campaign investment picks
2013/8/21
Actress, Singer and Dancer Appears in Public Service Announcements for QVC Presents "FFANY Shoes on Sale" WEST CHESTER, Pa.
Sign-up for Julianne Hough Proves That Fighting Breast Cancer Is Good For The Sole investment picks
Fifth Third Bank announces the launch of the Fifth Third Stand Up To Cancer (SU2C) Credit Card.
Sign-up for Fifth Third Bank Introduces Stand Up To Cancer® Credit Card To Drive Additional Funding for Cancer Research investment picks
2014/1/28
Annual World Cancer Day part of ongoing international campaign to challenge government leaders, providers and individuals to step up the fight against cancer PALO ALTO, Calif.
Sign-up for Varian Medical Systems Joins Global Community in Promoting World Cancer Day investment picks
Ticketmaster & The Princess Margaret Cancer Foundation Partner To Help Conquer Cancer With Online Donation Campaign Canada NewsWire - Proceeds Raised for Entire Month of October through Ticketmaster.Ca to Benefit Canada's Leading Cancer Research Centre - TORONTO , Nov.
Sign-up for Ticketmaster & The Princess Margaret Cancer Foundation Partner To Help Conquer Cancer With Online Donation Campaign investment picks
2013/10/23
Advaxis, Inc., (NASDAQ:ADXS)(NASDAQ:ADXSW), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that the first patient has been dosed in REALISTIC , a Phase 1 study being funded by Cancer Research UK (CRUK) to investigate the use of ADXS-HPV for the treatment of HPV-positive head and neck cancer.
Sign-up for Advaxis Announces First Patient Dosed with ADXS-HPV in Head and Neck Cancer Study investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0911328001&sourceType=1 http://media3.marketwire.com/logos/20131113-pg3.jpg TORONTO, ONTARIO --
Sign-up for Panacea Global to Participate in 2013 World Cancer Leaders' Summit investment picks
2014/2/11
Partnership to Raise Money for Research Grants Exploring the Impact of Healthy Living on Cancer & Cancer Related Diseases OWINGS MILLS, Md.
Sign-up for Medifast Announces Partnership with The V Foundation for Cancer Research investment picks
2014/2/27
MINNEAPOLIS , Feb.
Sign-up for Regis Foundation for Breast Cancer Research donates $400,000 to Masonic Cancer Center investment picks
2013/9/27
September 27, 2013 – Dendreon Corporation (NASDAQ: DNDN ) announced today the presentation of data from clinical studies featuring PROVENGE ® (sipuleucel-T), an autologous cellular immunotherapy for metastatic castrate-resistant prostate cancer (mCRPC), at the 2013 European Cancer Congress in Amsterdam, September 27-October 1, 2013.
Sign-up for Dendreon Corporation Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 European Cancer Congress investment picks
2013/10/1
LOUISVILLE, Ky., Oct.
Sign-up for CafePress Unveils Campaign to Support The Breast Cancer Research Foundation(R) investment picks
2013/12/9
http://media.marketwire.com/attachments/201310/193961_ROSG10-10-2013.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1074640&ProfileId=051205&sourceType=1 PRINCETON, NJ and REHOVOT, ISRAEL --
Sign-up for Rosetta Genomics Announces New York State Approval for the Rosetta Kidney Cancer Test(TM) investment picks
MINNEAPOLIS , Jan.
Sign-up for Regis Foundation for Breast Cancer Research donates $400,000 to Mayo Clinic investment picks
2013/9/26
-- Additional Phase III Top-Line Results in Other Tumor Types Expected in 2014 --
Sign-up for Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint investment picks
American is Raising Funds for Breast Cancer Research at MD Anderson in Houston FORT WORTH, Texas , Oct.
Sign-up for American Airlines Invites Customers To Observe National Breast Cancer Awareness Month, Earn Extra AAdvantage Miles Through Oct. 31 investment picks
Ingersoll Rand, a global leader in air compressors, tools, fluid management and material handling equipment, and the Ingersoll Rand Foundation presented a $25,000 grant to the National Breast Cancer Foundation to help fund the foundation’s Early Detection Plan, educational programs, online support communities, mammogram and diagnostics services and breast cancer research as part of the “Give Cancer the Boot” breast cancer awareness campaign.
Sign-up for Ingersoll Rand Donates $25,000 to National Breast Cancer Foundation, Inc.® as part of ‘Give Cancer the Boot’ Campaign investment picks
SALT LAKE CITY, Oct.
Sign-up for Myriad myPlan(TM) Lung Cancer Test Launched to Leading Oncologists investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Cancer Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Canadians Planning  |  Next: Cancer Research Annual